Azetidine derivatives as CCR-3 receptor antagonists

Details for Australian Patent Application No. 2003227072 (hide)

Owner Novartis AG

Inventors McCarthy, Clive; Walker, Clive Victor; Le Grand, Darren Mark; Woods, John James

Agent Davies Collison Cave

Pub. Number AU-B-2003227072

PCT Number PCT/EP03/02715

PCT Pub. Number WO2003/077907

Priority 0229627.5 19.12.02 GB; 0206218.0 15.03.02 GB

Filing date 14 March 2003

Wipo publication date 29 September 2003

Acceptance publication date 10 August 2006

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0229627.5 19.12.02 GB; 0206218.0 15.03.02 GB

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003227072

10 August 2006 Application Accepted

  Published as AU-B-2003227072

7 December 2006 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003227073-METHOD FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION

2003227071-CG8327, CG10823, CG18418, CG15862, CG3768, CG11447 AND CG16750 HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS